Proliferation markers and their uses in the study of endocrine tumors

Giuseppe Pelosi, Giuseppe Zamboni

Research output: Contribution to journalArticlepeer-review


A growing body of literature supports the view that the proliferative activity (PA) of tumor cells is an important prognostic indicator for a variety of different tumors. We examined the role of PA in diagnosis and prediction or malignancy of endocrine tumors (ETs) of pituitary gland, pancreas, thyroid, parathyroid glands, adrenal glands, paraganglia, gastroenteric tract, and lung. The data in the literature indicate that the assessment of PA is not a diagnostic indicator of malignancy especially at the individual case level, whereas it can be useful for identifying subsets of malignant tumors with different aggressiveness potential, as well as for choosing therapeutic options in metatstatic lesions. We hope that, in the near future, multiparametric approaches including PA markers, cell growth and differentiation factors, and oncogenes will yield valuable information for diagnosis and prognosis of ETs also in individual cases.

Original languageEnglish
Pages (from-to)103-119
Number of pages17
JournalEndocrine Pathology
Issue number2
Publication statusPublished - May 1996


  • Adrenal glands
  • Endocrine tumors (ETs)
  • Extra-adrenal paraganglia
  • Gastrointestinal tract
  • Immunohistochemistry
  • Lung
  • Pancreas
  • Parathyroid glands
  • Pituitary gland
  • Prognosis
  • Proliferative activity (PA)
  • Survival
  • Thyroid

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Pathology and Forensic Medicine


Dive into the research topics of 'Proliferation markers and their uses in the study of endocrine tumors'. Together they form a unique fingerprint.

Cite this